RecruitingPhase 4NCT06793982

Platelet Rich Plasma Versus Corticosteroids in Hip Osteoarthritis Pain

The Efficacy of Platelet Rich Plasma Compared With Corticosteroid Injections for the Treatment of Pain Associated With Hip Osteoarthritis

Sponsor

LifeBridge Health

Enrollment

54 participants

Start Date

Feb 21, 2024

Study Type

INTERVENTIONAL

Conditions

hip osteoarthritis

Summary

Prospective, single-center that may go on to being multicenter, randomized trial comparing platelet rich plasma (PRP) versus corticosteroid injection for the treatment of symptoms of Hip osteoarthritis. The purpose of the study is to determine which therapy provides a greater reduction in patient reported outcome measures of pain and function.

Eligibility

Min Age: 21 YearsMax Age: 80 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Corticosteroid Injection and a medical device called Platelet Rich Plasma Joint Injection for people with hip osteoarthritis. The study is currently recruiting participants at 1 location. People eligible for this study include aged 21 Years to 80 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEPlatelet Rich Plasma Joint Injection

Magellan Autologous Concentration System, ISTO Biologics

DRUGCorticosteroid Injection

5 milliliters (mL) injection of corticosteroid (1cc Kenalog, 4cc Xylocaine) Kenalog - 40 (triamcinolone acetonide injectable suspension, USP) Xylocaine - MPF (lidocaine HCl Injection, USP)